Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Merck KGaA Partners with IMEC to Develop Advanced Microphysiological Systems Platform
May 21, 2025
Company
Deals
Antengene and MSD Collaborate on ATG-022 for Advanced Solid Tumors
May 21, 2025
Hospital
Policy / Regulatory
China’s County Hospitals Show Improved Medical Service Capability in 2024
May 21, 2025
Company
Drug
3SBio Registers Phase III Study for SSGJ-707 in Advanced NSCLC
May 21, 2025
Company
Drug
Ascletis Pharma Initiates ASC47-103 Study in US for Obesity Treatment
May 21, 2025
Company
Deals
Yifan Pharma Licenses Ryzneuta to Lenis for Balkan Markets
May 21, 2025
Company
Drug
Abbisko’s Pimitinib Granted Priority Review for TGCT Treatment in China
May 21, 2025
Company
Drug
Minghui Pharmaceutical Launches Phase II Study of Combination Therapy for Advanced NSCLC
May 21, 2025
Company
Drug
CSPC Pharmaceutical Gains NMPA Approval for JMT106 Clinical Study in Solid Tumors
May 21, 2025
Company
Drug
Zhaoke Ophthalmology’s Cyclosporine Eye Gel NDA Accepted by NMPA
May 21, 2025
Company
Medical Device
Johnson & Johnson MedTech Completes First PFA Surgeries with VARIPULSE Catheter in China
May 21, 2025
Company
Deals
Shanghai CureGene Completes Series B+ Financing to Advance CG-0255 Study
May 21, 2025
1
2
…
159
160
161
162
163
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?